Clinical Trial Update: Liquid Biopsy Based NGS in Newly Diagnosed NSCLC [NA]

View source ↗

Summary

A clinical trial evaluating liquid biopsy-based next-generation sequencing in newly diagnosed non-small cell lung cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Charu Aggarwal | Conditions: Non Small Cell Lung Cancer Metastatic, Newly Diagnosed NSCLC | NA | Status: ACTIVE_NOT_RECRUITING